Search

Your search keyword '"Sangaré I"' showing total 103 results

Search Constraints

Start Over You searched for: Author "Sangaré I" Remove constraint Author: "Sangaré I"
103 results on '"Sangaré I"'

Search Results

1. Genotype Analysis of Clinical Candida albicans Isolates Using PCRs Targeting 25S rDNA and ALT Repeat Sequences of the RPS and Antifungal Susceptibility in Ouagadougou (Burkina Faso)

3. Cutaneous leishmaniasis in Burkina Faso: Epidemiological evolution of a vector-borne disease locally called 'Ouaga 2000 disease': a minireview

7. Hyperimmune malarial splenomegaly in a malaria-endemic area of southwest Burkina Faso: case of Bobo-Dioulasso

8. Obésité (ob) adulte : Evolution sur 11 ans et facteurs prédictifs a Bamako : Study of adult obesity (OB): Evolution over 11 years and predictive factors in Bamako

10. Detection and molecular characterization of multiresistant Enterobacteriaceae carried by houseflies in the city of Bobo-Dioulasso, Burkina Faso

12. Characterisation of the Breeding Sites and Insecticide Resistance of Aedes aegypti Population in the City of Bobo-Dioulaso, Burkina Faso

13. Epidemio-Clinical, Therapeutic and Evolutive Aspects of Pulmonary Embolism in Young Subject in the Cardiology Department in Point “G” Hospital University Center Bamako

14. ASPECTS EPIDEMIOLOGIQUE ET CLINIQUE DE LA FIBRILLATION AURICULAIRE AU SERVICE DE CARDIOLOGIE DU CHU DE KATI.

15. Complications macro-angiopathiques du diabete a l’hopital du Mali de Bamako

17. Partial Ventricular Atrioventricular Canal Aged about a Case

19. Onchocercose au Burkina Faso : une endémie à transmission vectorielle en voie de réémergence.

21. Cardiopathie rhumatismale à Bamako : A propos de 52 cas

23. HIV and Malaria Co infection in the Department of Paediatrics of the University Teaching Hospital Souro Sanou

26. Prévalence de l’ankylostomiase avant et après la mise en oeuvre du traitement de masse à l’ivermectine et à l’albendazole au Burkina Faso

29. Differences in the Cardiovascular Risk Assessment in Cardiology Outpatients in Mali: Comparison between Framingham Body Mass Index-Based Tool and Low-Information World Health Organization Chart

30. FACTEURS DE RISQUE ET ASPECTS CLINIQUES DE L'INFARCTUS DU MYOCARDE CHEZ LES PATIENTS DE MOINS DE 40 ANS AU CHU DU POINT G.

31. LES INDICATIONS ET ANOMALIES DE L'ENREGISTREMENT DE LONGUE DUREE (24 HEURES) DE L'ELECTROCARDIOGRAMME AU CHU GABRIEL TOURE DE BAMAKO.

32. Digestive fungal flora in asymptomatic subjects in Bobo-Dioulasso, Burkina Faso

33. Chikungunya (Togaviridae) and dengue 2 (Flaviviridae) viruses detected from Aedes aegypti mosquitoes in Burkina Faso by qRT-PCR technique: preliminary results and perspective for molecular characterisation of arboviruses circulation in vector populations

34. Sandflies of the south part of Ouagadougou City, Burkina Faso

35. INVAGINATION INTESTINALE SUR GROSSESSE : 1cas.

36. Studying fitness cost of Plasmodium falciparum infection in malaria vectors: validation of an appropriate negative control

37. Utilization of novel molecular multiplex methods for the detection and, epidemiological surveillance of dengue virus serotypes and chikungunya virus in Burkina Faso, West Africa.

38. Epidemiological, clinical, diagnostic, and therapeutic features of histoplasmosis: A systematic review.

39. Assessment of Culicidae collection methods for xenomonitoring lymphatic filariasis in malaria co-infection context in Burkina Faso.

40. Development of Multiplex Molecular Assays for Simultaneous Detection of Dengue Serotypes and Chikungunya Virus for Arbovirus Surveillance.

41. Situation of onchocerciasis transmission in 2020 in the Cascades region of Burkina Faso.

42. Schistosomiasis in Burkina Faso: review on 60 years' research.

43. Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso.

44. Serological and molecular detection of Leishmania species in dog peripheral blood from Bobo-Dioulasso city, a confirmation of canine leishmaniasis enzootic area for Burkina Faso.

45. Spatial-temporal pattern of malaria in Burkina Faso from 2013 to 2020.

46. [Epidemiological and clinical aspects of atrial fibrillation at the cardiology department of kati university hospital].

47. Antimalarial drugs resistance genes of Plasmodium falciparum: a review.

48. Insecticide resistance profiles in malaria vector populations from Sud-Kivu in the Democratic Republic of the Congo.

49. Otomycosis in Africa: Epidemiology, diagnosis and treatment.

50. Malaria vectors diversity, insecticide resistance and transmission during the rainy season in peri-urban villages of south-western Burkina Faso.

Catalog

Books, media, physical & digital resources